150 related articles for article (PubMed ID: 35515894)
1. Cisplatin, glutathione and the third wheel: a copper-(1,10-phenanthroline) complex modulates cisplatin-GSH interactions from antagonism to synergism in cancer cells resistant to cisplatin.
Vascellari S; Valletta E; Perra D; Pinna E; Serra A; Isaia F; Pani A; Pivetta T
RSC Adv; 2019 Feb; 9(10):5362-5376. PubMed ID: 35515894
[TBL] [Abstract][Full Text] [Related]
2. Competitive reactions among glutathione, cisplatin and copper-phenanthroline complexes.
Cadoni E; Valletta E; Caddeo G; Isaia F; Cabiddu MG; Vascellari S; Pivetta T
J Inorg Biochem; 2017 Aug; 173():126-133. PubMed ID: 28511063
[TBL] [Abstract][Full Text] [Related]
3. Mixed copper-platinum complex formation could explain synergistic antiproliferative effect exhibited by binary mixtures of cisplatin and copper-1,10-phenanthroline compounds: An ESI-MS study.
Pivetta T; Lallai V; Valletta E; Trudu F; Isaia F; Perra D; Pinna E; Pani A
J Inorg Biochem; 2015 Oct; 151():107-14. PubMed ID: 26021964
[TBL] [Abstract][Full Text] [Related]
4. Novel copper(II) complexes as new promising antitumour agents. A crystal structure of [Cu(1,10-phenanthroline-5,6-dione)2(OH2)(OClO3)](ClO4).
Pivetta T; Trudu F; Valletta E; Isaia F; Castellano C; Demartin F; Tuveri R; Vascellari S; Pani A
J Inorg Biochem; 2014 Dec; 141():103-113. PubMed ID: 25238635
[TBL] [Abstract][Full Text] [Related]
5. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
Lau DH; Lewis AD; Ehsan MN; Sikic BI
Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140
[TBL] [Abstract][Full Text] [Related]
6. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.
Mistry P; Kelland LR; Abel G; Sidhar S; Harrap KR
Br J Cancer; 1991 Aug; 64(2):215-20. PubMed ID: 1892748
[TBL] [Abstract][Full Text] [Related]
7. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
Mistry P; Loh SY; Kelland LR; Harrap KR
Int J Cancer; 1993 Nov; 55(5):848-56. PubMed ID: 8244583
[TBL] [Abstract][Full Text] [Related]
8. Carbon monoxide sensitizes cisplatin-resistant ovarian cancer cell lines toward cisplatin via attenuation of levels of glutathione and nuclear metallothionein.
Kawahara B; Ramadoss S; Chaudhuri G; Janzen C; Sen S; Mascharak PK
J Inorg Biochem; 2019 Feb; 191():29-39. PubMed ID: 30458366
[TBL] [Abstract][Full Text] [Related]
9. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
[TBL] [Abstract][Full Text] [Related]
10. Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.
Peters RH; Jollow DJ; Stuart RK
Cancer Res; 1991 May; 51(10):2536-41. PubMed ID: 2021933
[TBL] [Abstract][Full Text] [Related]
11. Glutathione depletion restores the susceptibility of cisplatin-resistant chronic myelogenous leukemia cell lines to Natural Killer cell-mediated cell death via necrosis rather than apoptosis.
Dedoussis GV; Andrikopoulos NK
Eur J Cell Biol; 2001 Sep; 80(9):608-14. PubMed ID: 11675936
[TBL] [Abstract][Full Text] [Related]
12. A novel heteroleptic Cu(II)-phenanthroline-UDCA complex as lipoxygenase inhibitor and ER-stress inducer in cancer cell lines.
Masuri S; Moráň L; Vesselá T; Cadoni E; Cabiddu MG; Pečinka L; Gabrielová V; Meloni F; Havel J; Vaňhara P; Pivetta T
J Inorg Biochem; 2023 Sep; 246():112301. PubMed ID: 37392615
[TBL] [Abstract][Full Text] [Related]
13. Sanguinarine enhances cisplatin sensitivity via glutathione depletion in cisplatin-resistant ovarian cancer (A2780) cells.
Sarkhosh-Inanlou R; Molaparast M; Mohammadzadeh A; Shafiei-Irannejad V
Chem Biol Drug Des; 2020 Feb; 95(2):215-223. PubMed ID: 31512406
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the cytotoxicity of the Bithionol - cisplatin combination in a panel of human ovarian cancer cell lines.
Ayyagari VN; Hsieh TJ; Diaz-Sylvester PL; Brard L
BMC Cancer; 2017 Jan; 17(1):49. PubMed ID: 28086831
[TBL] [Abstract][Full Text] [Related]
15. Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O6-benzylguanine.
Fishel ML; Gamcsik MP; Delaney SM; Zuhowski EG; Maher VM; Karrison T; Moschel RC; Egorin MJ; Dolan ME
Cancer Chemother Pharmacol; 2005 Apr; 55(4):333-342. PubMed ID: 15723259
[TBL] [Abstract][Full Text] [Related]
16. The cytotoxicity of some phenanthroline-based antimicrobial copper(II) and ruthenium(II) complexes.
Ng NS; Wu MJ; Aldrich-Wright JR
J Inorg Biochem; 2018 Mar; 180():61-68. PubMed ID: 29247868
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of lipoic acid and glutathione against cisplatin-induced ototoxicity in auditory cells.
Koo DY; Lee SH; Lee S; Chang J; Jung HH; Im GJ
Int J Pediatr Otorhinolaryngol; 2016 Dec; 91():30-36. PubMed ID: 27863638
[TBL] [Abstract][Full Text] [Related]
18. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts.
Goddard P; Valenti M; Kelland LR
Anticancer Res; 1994; 14(3A):1065-70. PubMed ID: 8074451
[TBL] [Abstract][Full Text] [Related]
19. Schedule-dependent antagonism of paclitaxel and cisplatin in human gastric and ovarian carcinoma cell lines in vitro.
Vanhoefer U; Harstrick A; Wilke H; Schleucher N; Walles H; Schröder J; Seeber S
Eur J Cancer; 1995; 31A(1):92-7. PubMed ID: 7695986
[TBL] [Abstract][Full Text] [Related]
20. Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistance.
Li L; Keating MJ; Plunkett W; Yang LY
Mol Pharmacol; 1997 Nov; 52(5):798-806. PubMed ID: 9351970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
